ClinConnect ClinConnect Logo
Search / Trial NCT05361590

Impact of Regular Home Use of Lumoral Dual-light Photodynamic Therapy on Plaque Control and Gingival Health

Launched by KOITE HEALTH OY · Apr 29, 2022

Trial Information

Current as of June 13, 2025

Completed

Keywords

Lumoral Lumorinse Plaque Periodontitis Plaque Control

ClinConnect Summary

Dental plaque triggers changes in gingival health, which results in slight swelling and bleeding from the gingival margin and causes gingivitis. Supragingival dental biofilm control can be achieved by mechanical and chemical means. Toothbrushing is effective in reducing levels of dental plaque (van der Weijden \& Slot 2015). It removes plaque from flat, accessible surfaces but is less effective at the gingival margins and in approximal areas, where the accumulation of residual plaque encourages gingivitis and deterioration of periodontal health. Effective toothbrushing is also depending on ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • At least 18 years old
  • Agreement to participate in the study and to sign a written consent form
  • Exclusion Criteria:
  • Presence of any physical limitation or restriction that might restrict Lumoral use
  • Pregnancy or lactation

About Koite Health Oy

Koite Health Oy is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. Based in Finland, the company specializes in designing and managing clinical trials that focus on cutting-edge therapies and medical technologies. With a commitment to improving patient outcomes, Koite Health Oy leverages a team of experienced professionals and robust methodologies to ensure the highest standards of quality and compliance throughout the research process. By fostering collaborations with healthcare providers and stakeholders, Koite Health Oy aims to bring transformative solutions to the market, enhancing the efficacy and accessibility of treatments for various medical conditions.

Locations

Tampere, Pirkanmaa, Finland

Tampere, Pirkanmaa, Finland

Patients applied

0 patients applied

Trial Officials

Tommi Pätilä, Docent

Study Director

Head of Research

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials